can i still get compounded glp-1 Medications for Seniors | Weight If it's not FDA-approved, it's

Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers

The MHRA has updated its GLP-1 guidance due to a risk of the rare occurence of NAION among semaglutide patients

GLP-1 medications reduce hunger powerfully but without nutrition support, companion and habit guidance, most people regain the weight.

Novo Nordisk was close behind, also generating nearly $12 billion, driven by massive demand for Ozempic and Wegovy

However, their exact effects remain unclear

Our bodies regulate food intake and energy expenditure via cells in the intestinal wall that sense certain nutrients, then release peptides which activate neurons